Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays revision label v3.3.2 and the previous v3.2.0 label is removed.SummaryDifference0.0%

- Check29 days agoChange DetectedThe notice about government funding and data currency was removed from the page. No new content was added.SummaryDifference0.3%

- Check50 days agoChange DetectedThe Study Details page shows only minor formatting adjustments with no changes to core study content, including eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check72 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference1%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.0%

- Check93 days agoChange DetectedUpdated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No core content changes are evident.SummaryDifference0.1%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.